Scanogen Overview
- Founded
-
2011

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$6.63M
- Investors
-
5
Scanogen General Information
Description
Operator of a biotechnology and medical device company intended to directly detect DNA. The company develops a technology for direct detection of DNA and it also offers Single Molecule Scanning, a technology for ultra-sensitive detection of biomolecules, enabling users to detect nucleic acid molecules.
Contact Information
Website
www.scanogen.com
Formerly Known As
Twistnostics LLC
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Primary Office
- 3102 Lord Baltimore Drive
- Suite 214
- Baltimore, MD 21244
- United States
Scanogen Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | 01-Jan-2017 | $6.63M | Completed | Startup | ||
2. Accelerator/Incubator | Completed | Startup | ||||
1. Grant | 19-Sep-2013 | $153K | Completed | Startup |
Scanogen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology and medical device company intended to directly detect DNA. The company develops a technolog
Other Devices and Supplies
Baltimore, MD
10
As of 2019
0000000000
Scanogen Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00 0000000000 | Formerly VC-backed | Lexington, MA | 000 | 00000 | 00000000000 | 00000 |
Scanogen Patents
Scanogen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190361016-A1 | Detection units and methods for detecting a target analyte | Pending | 25-May-2018 | 000000000000 | |
US-20190040344-A1 | Device and method for sample analysis | Abandoned | 27-Jul-2017 | 000000000 | |
US-10768406-B2 | Imaging system | Active | 20-Jun-2016 | 0000000000 | 0 |
US-20170363851-A1 | Imaging system | Granted | 20-Jun-2016 | 0000000000 | 0 |
US-20200400932-A1 | Imaging system | Pending | 20-Jun-2016 | G02B21/361 |
Scanogen Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Alfredo Celedon Ph.D | Founder & Chief Executive Officer |
Scanogen Signals
Scanogen Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
National Cancer Institute | Government | 000 0000 | 000000 0 | ||
The National Human Genome Research Institute | Government | 000 0000 | 000000 0 | ||
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |